Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, giving promising improvements throughout different health-related and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, far more responsible option for therapeutic use,